Showing results (181-190 of 454) with videos related to

Sort By:
Pageof 46
Diabetic Medicine : a Journal of the British Diabetic Association|March 25, 2005
A long-term comparison of pioglitazone and gliclazide in patients with Type 2 diabetes mellitus: a randomized, double-blind, parallel-group comparison trialB H Charbonnel, D R Matthews, G Schernthaner, et al.
Diabetes/Metabolism Research and Reviews|September 24, 2004
Long-term therapy with addition of pioglitazone to metformin compared with the addition of gliclazide to metformin in patients with type 2 diabetes: a randomized, comparative studyD R Matthews, B H Charbonnel, M Hanefeld, et al.
European Journal of Internal Medicine|March 15, 2002
Insulin resistance and metabolic parameters in type 2 diabetic patientsW Metzler, S Fischer, C Köhler, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|June 16, 2010
Effect of targeting normal fasting glucose levels with basal insulin glargine on glycaemic variability and risk of hypoglycaemia: a randomized, controlled study in patients with early Type 2 diabetesM Hanefeld, C Koehler, C Hoffmann, et al.
Journal of the American Society of Nephrology : JASN|January 19, 1999
Intracellular actions of angiotensin II in vascular smooth muscle cellsH Haller, C Lindschau, P Quass, et al.
Development Genes and Evolution|January 31, 2002
Adenovirus-mediated gene transfer as a tool to study angiogenesis in the chick embryoM B Hautmann, J Wilting, H Haller, et al.
Der Internist|February 22, 2015
[Rare forms of hypertension : From pheochromocytoma to vasculitis]H Haller, F Limbourg, B M Schmidt, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|December 9, 2008
Effects of the alpha glucosidase inhibitor acarbose on endothelial function after a mixed meal in newly diagnosed type 2 diabetesF Pistrosch, F Schaper, J Passauer, et al.
Biomedica Biochimica Acta|January 1, 1988
Is the level of steroid hormones in the low density lipoprotein (LDL) particles responsible for the prostaglandin I2 inhibitory potency of LDL?J Beitz, K Schollberg, S Fischer, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 1, 1996
Endothelial cell tyrosine kinase receptor and G protein-coupled receptor activation involves distinct protein kinase C isoformsH Haller, W Ziegler, C Lindschau, et al.
Pageof 46